Breast Specific Genes and Proteins

a gene and gene technology, applied in the field of newly identified polynucleotides and polypeptides, can solve the problems of poor treatment and many breast masses discovered

Inactive Publication Date: 2006-11-16
HUMAN GENOME SCI INC
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

Enables early and accurate detection of breast cancer and metastases by targeting specific genetic markers, improving diagnostic precision and potentially reducing the need for invasive tests.

Problems solved by technology

Unfortunately, so few periodic self-examinations are made that many breast masses are discovered only by accidental palpation.
Breast cancer is rare in men, but when it does occur, it usually not recognized until late, and thus the results of treatment are poor.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Breast Specific Genes and Proteins
  • Breast Specific Genes and Proteins
  • Breast Specific Genes and Proteins

Examples

Experimental program
Comparison scheme
Effect test

example 1

Determination of Transcription of a Breast Specific Gene

[0169] To assess the presence or absence of active transcription of a breast specific gene RNA, approximately 6 ml of venous blood is obtained with a standard venipuncture technique using heparinized tubes. Whole blood is mixed with an equal volume of phosphate buffered saline, which is then layered over 8 ml of Ficoll (Pharmacia, Uppsala, Sweden) in a 15-ml polystyrene tube. The gradient is centrifuged at 1800×g for 20 min at 5 C. The lymphocyte and granulocyte layer (approximately 5 ml) is carefully aspirated and rediluted up to 50 ml with phosphate-buffered saline in a 50-ml tube, which is centrifuged again at 1800×g for 20 min. at 5 C. The supernatant is discarded and the pellet containing nucleated cells is used for RNA extraction using the RNazole B method as described by the manufacturer (Tel-Test Inc., Friendswood, Tex.).

[0170] To determine the quantity of mRNA, a probe is designed with an identity to at least a porti...

example 2

Bacterial Expression and Purification of the BSG Proteins and Use for Preparing a Monoclonal Antibody

[0173] The DNA sequence encoding a polypeptide of the present invention, for this example BSG1, ATCC # 97175, is initially amplified using PCR oligonucleotide primers corresponding to the 5′ sequences of the protein and the vector sequences 3′ to the protein. Additional nucleotides corresponding to the DNA sequence are added to the 5′ and 3′ sequences respectively. The 5′ oligonucleotide primer has the sequence 5′ GCCACCATGGATGTTTTCAAG 3′ (SEQ ID NO:25) and contains an NcoI restriction enzyme site followed by 15 nucleotides of coding sequence starting from the initial amino acid of the processed protein. The 3′ sequence 5′ GCGCAGATCTGTCTCCCCCACTCTGGGC 3′ (SEQ ID NO:26) and contains a complementary sequence to a BgII restriction enzyme site and is followed by 18 nucleotides of the nucleic acid sequence encoding the protein. The restriction enzyme sites correspond to the restriction e...

example 3

Preparation of cDNA Libraries from Breast Tissue

[0176] Total cellular RNA is prepared from tissues by the guanidinium-phenol method as previously described (P. Chomczynski and N. Sacchi, Anal. Biochem., 162: 156-159 (1987)) using RNAzol (Cinna-Biotecx). An additional ethanol precipitation of the RNA is included. Poly A mRNA is isolated from the total RNA using oligo dT-coated latex beads (Qiagen). Two rounds of poly A selection are performed to ensure better separation from non-polyadenylated material when sufficient quantities of total RNA are available.

[0177] The mRNA selected on the oligo dT is used for the synthesis of cDNA by a modification of the method of Gobbler and Hoffman (Gobbler, U. and B. J. Hoffman, 1983, Gene, 25:263). The first strand synthesis is performed using either Moloney murine sarcoma virus reverse transcriptase (Stratagene) or Superscript II (RNase H minus Moloney murine reverse transcriptase, Gibco-BRL). First strand synthesis is primed using a primer / lin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
body weightaaaaaaaaaa
volumeaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

Human breast specific gene polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polynucleotides or polypeptides as a diagnostic marker for breast cancer and as an agent to determine if breast cancer has metastasized. Also disclosed are antibodies specific to the breast specific gene polypeptides which may be used to target cancer cells and be used as part of a breast cancer vaccine. Methods of screening for antagonists for the polypeptide and therapeutic uses thereof are also disclosed.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a divisional of U.S. application Ser. No. 10 / 267,849, filed Oct. 10, 2002, which is a continuation of U.S. application Ser. No. 08 / 673,284, filed Jun. 28, 1996; claims benefit under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 60 / 000,602, filed Jun. 30, 1995; each of which is hereby incorporated by reference in its entirety.BACKGROUND OF THE INVENTION [0002] This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, and the use of such polynucleotides and polypeptides for detecting disorders of the breast, particularly the presence of breast cancer and breast cancer metastases. The present invention further relates to inhibiting the production and function of the polypeptides of the present invention. The twenty breast specific genes of the present invention are sometimes hereinafter referred to as “BSG1”, “BSG2” etc. [0003] The mammary gland is subject to a va...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): A61K48/00C12Q1/68G01N33/574C07H21/04A61K39/395C07K14/82C07K16/30A61K39/00C07K14/47
CPCA61K39/00C07K14/47C12Q1/6809C12Q1/6886C12Q2600/156G01N2500/04G01N33/57415C12Q2539/113
InventorJI, HONGJUNROSEN, CRAIG
OwnerHUMAN GENOME SCI INC